Jeffrey A. Silverman
- Oncology top 1%
- Molecular Biology top 10%
- Pediatrics, Perinatology and Child Health top 1%
- Pharmacology top 0.5%
- Biomaterials top 2%
- Co-authors
- Jay DintamanSteven R. DeitcherVincent J. WacherLeslie Z. BenetSnorri S. ThorgeirssonYuanchao ZhangTimothy W. GantDieter Schrenk
- Topics
- Drug Transport and Resistance Mechanisms (31 papers)Acute Lymphoblastic Leukemia research (15 papers)Pharmacological Effects and Toxicity Studies (12 papers)
- Journals
- Nucleic Acids ResearchJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Jeffrey A. Silverman
90 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 2.0k
- Molecular Biology 1.1k
- Pediatrics, Perinatology and Child Health 856
- Pharmacology 619
- Biomaterials 450
Countries citing papers authored by Jeffrey A. Silverman
This map shows the geographic impact of Jeffrey A. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Silverman more than expected).
Fields of papers citing papers by Jeffrey A. Silverman
This network shows the impact of papers produced by Jeffrey A. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Silverman. The network helps show where Jeffrey A. Silverman may publish in the future.
Co-authorship network of co-authors of Jeffrey A. Silverman
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Silverman. A scholar is included among the top collaborators of Jeffrey A. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Silverman. Jeffrey A. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 10 | |
| 5 | 78 | |
| 6 | 24 | |
| 7 | 19 | |
| 8 | 66 | |
| 9 | 52 | |
| 10 | SNS-032 has potent antitumor activity in vivo against human leukemia and multiple myeloma xenografts | 2 |
| 11 | SNS-595 potentiates the in vivo antitumor activity of carboplatin, cisplatin, and gemcitabine in solid tumor xenografts. | 3 |
| 12 | 30 | |
| 13 | 22 | |
| 14 | 219 | |
| 15 | 367 | |
| 16 | 151 | |
| 17 | 39 | |
| 18 | 7 | |
| 19 | 72 | |
| 20 | 60 |
About Jeffrey A. Silverman
Jeffrey A. Silverman is a scholar working on Oncology, Biochemistry and Genetics, having authored 93 papers that have together received 3.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (31 papers), Acute Lymphoblastic Leukemia research (15 papers) and Pharmacological Effects and Toxicity Studies (12 papers). The work is most often cited by research in Oncology (2.0k citations), Pharmacology (619 citations) and Pharmaceutical Science (335 citations). Jeffrey A. Silverman has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Jay Dintaman, Steven R. Deitcher, Vincent J. Wacher, Leslie Z. Benet, Snorri S. Thorgeirsson, Yuanchao Zhang, Timothy W. Gant, Dieter Schrenk, Pamela A. Marino and Takashi Izumi. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.